{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T01:19:32Z","timestamp":1794273572347,"version":"4.9.0"},"reference-count":6,"publisher":"American Medical Association (AMA)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Oncol"],"published-print":{"date-parts":[[2023,11,1]]},"abstract":"<jats:p>This cohort study examines the incidence, risks, and characteristics of deep vein thrombosis, pulmonary embolism, arterial thrombosis, and stroke among patients with non\u2013small cell lung cancer (NSCLC) and <jats:italic>RET<\/jats:italic> fusions.<\/jats:p>","DOI":"10.1001\/jamaoncol.2023.3625","type":"journal-article","created":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T15:10:56Z","timestamp":1694704256000},"page":"1583","source":"Crossref","is-referenced-by-count":12,"title":["Prevalence of Thromboembolic Events in Patients With Non\u2013Small Cell Lung Cancer and <i>RET<\/i> Fusions"],"prefix":"10.1001","volume":"9","author":[{"given":"Mihaela","family":"Aldea","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, International Center for Thoracic Cancers (CICT), Gustave Roussy, Villejuif, France"},{"name":"Faculty of Medicine, Paris Saclay University, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna","family":"Marinello","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, International Center for Thoracic Cancers (CICT), Gustave Roussy, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Guyon","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Neuro-oncology Unit, Gustave Roussy, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anas","family":"Gazzah","sequence":"additional","affiliation":[{"name":"Department of Drug Development Department, CICT, Gustave Roussy, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice","family":"Barlesi","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, International Center for Thoracic Cancers (CICT), Gustave Roussy, Villejuif, France"},{"name":"Faculty of Medicine, Paris Saclay University, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Planchard","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, International Center for Thoracic Cancers (CICT), Gustave Roussy, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Besse","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, International Center for Thoracic Cancers (CICT), Gustave Roussy, Villejuif, France"},{"name":"Faculty of Medicine, Paris Saclay University, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"8","key":"cld230014r1","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1097\/JTO.0b013e31811ea275","article-title":"High risk of deep vein thrombosis in patients with non-small cell lung cancer: a cohort study of 493 patients.","volume":"2","author":"Tagalakis","year":"2007","journal-title":"J Thorac Oncol"},{"issue":"1","key":"cld230014r2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41572-022-00336-y","article-title":"Cancer-associated venous thromboembolism.","volume":"8","author":"Khorana","year":"2022","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"cld230014r3","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/bjc.2016.143","article-title":"Risk of venous thromboembolism in people with lung cancer: a cohort study using linked UK healthcare data.","volume":"115","author":"Walker","year":"2016","journal-title":"Br J Cancer"},{"issue":"3","key":"cld230014r4","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.21037\/tlcr","article-title":"High discrepancy in thrombotic events in non-small cell lung cancer patients with different genomic alterations.","volume":"10","author":"Liu","year":"2021","journal-title":"Transl Lung Cancer Res"},{"issue":"5","key":"cld230014r5","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.jtho.2022.12.018","article-title":"RET-MAP: an international multicenter study on clinicobiologic features and treatment response in patients with lung cancer harboring a RET fusion.","volume":"18","author":"Aldea","year":"2023","journal-title":"J Thorac Oncol"},{"issue":"12","key":"cld230014r6","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1016\/j.trecan.2021.07.003","article-title":"Precision therapy for RET-altered cancers with RET inhibitors.","volume":"7","author":"Thein","year":"2021","journal-title":"Trends Cancer"}],"container-title":["JAMA Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/articlepdf\/2809585\/jamaoncology_aldea_2023_ld_230014_1699901613.26757.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T16:05:37Z","timestamp":1700150737000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/fullarticle\/2809585"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,1]]},"references-count":6,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoncol.2023.3625","relation":{},"ISSN":["2374-2437"],"issn-type":[{"value":"2374-2437","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11,1]]}}}